Irritable bowel syndrome with constipation (IBS-C)
Clinical trials for Irritable bowel syndrome with constipation (IBS-C) explained in plain language.
Never miss a new study
Get alerted when new Irritable bowel syndrome with constipation (IBS-C) trials appear
Sign up with your email to follow new studies for Irritable bowel syndrome with constipation (IBS-C), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug tested for kids with chronic constipation
Symptom relief By invitation onlyThis study is testing the long-term safety of tenapanor (Ibsrela) in children aged 6 to 17 with irritable bowel syndrome with constipation (IBS-C). About 150 kids who completed a prior study will continue taking the drug for up to one year. Researchers will monitor side effects a…
Matched conditions: IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C)
Phase 3 • Sponsor: Ardelyx • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New drug could ease teen IBS constipation pain
Symptom relief OngoingThis phase 3 trial tests tenapanor, a drug that helps with constipation and belly pain, in 180 teenagers aged 12 to 17 with irritable bowel syndrome and constipation (IBS-C). Participants take either a low or high dose of tenapanor or a placebo twice daily for 12 weeks. The goal …
Matched conditions: IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C)
Phase 3 • Sponsor: Ardelyx • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC